Press releases from Eli Lilly or local Indiana news reports

Eli Lilly Announces $5.3 Billion Investment in Indiana to Expand Drug Manufacturing by 2028

May 24, 2024, 06:42 PM

Eli Lilly announced a $5.3 billion investment to expand manufacturing for its drugs Mounjaro and Zepbound in Indiana. The new facility, which is expected to be operational by 2028, will be the largest site in the U.S. for active pharmaceutical ingredients, according to CEO David Ricks. This investment is part of Eli Lilly's strategy to meet growing demand and capitalize on the expanding market for health-related products. Bank of America has high revenue expectations for Eli Lilly's upcoming drug launches, which Ricks believes are achievable given the current market dynamics.